Catalyst Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Sell |
65
-20
| -24% | -$10.5K | ﹤0.01% | 416 |
|
|
2025
Q1 | $53.9K | Buy |
85
+1
| +1% | +$634 | ﹤0.01% | 360 |
|
|
2024
Q4 | $59.8K | Hold |
84
| – | – | ﹤0.01% | 364 |
|
|
2024
Q3 | $88.3K | Sell |
84
-20
| -19% | -$21K | ﹤0.01% | 283 |
|
|
2024
Q2 | $109K | Buy |
104
+3
| +3% | +$3.15K | ﹤0.01% | 223 |
|
|
2024
Q1 | $97.2K | Buy |
101
+1
| +1% | +$962 | ﹤0.01% | 216 |
|
|
2023
Q4 | $87.8K | Buy |
100
+20
| +25% | +$17.6K | ﹤0.01% | 205 |
|
|
2023
Q3 | $65.8K | Buy |
80
+21
| +36% | +$17.3K | ﹤0.01% | 239 |
|
|
2023
Q2 | $42.4K | Buy |
59
+1
| +2% | +$719 | ﹤0.01% | 270 |
|
|
2023
Q1 | $47.7K | Sell |
58
-26
| -31% | -$21.4K | ﹤0.01% | 254 |
|
|
2022
Q4 | $60.6K | Sell |
84
-1
| -1% | -$721 | ﹤0.01% | 248 |
|
|
2022
Q3 | $59K | Hold |
85
| – | – | ﹤0.01% | 250 |
|
|
2022
Q2 | $50K | Sell |
85
-57
| -40% | -$33.5K | ﹤0.01% | 276 |
|
|
2022
Q1 | $99K | Buy |
142
+84
| +145% | +$58.6K | ﹤0.01% | 264 |
|
|
2021
Q4 | $37K | Sell |
58
-31
| -35% | -$19.8K | ﹤0.01% | 310 |
|
|
2021
Q3 | $54K | Buy |
89
+24
| +37% | +$14.6K | ﹤0.01% | 302 |
|
|
2021
Q2 | $36K | Buy |
65
+3
| +5% | +$1.66K | ﹤0.01% | 326 |
|
|
2021
Q1 | $29K | Sell |
62
-12
| -16% | -$5.61K | ﹤0.01% | 301 |
|
|
2020
Q4 | $36K | Buy |
+74
| New | +$36K | ﹤0.01% | 280 |
|
|
2019
Q2 | – | Sell |
-100
| Closed | -$41K | – | 465 |
|
|
2019
Q1 | $41K | Buy |
+100
| New | +$41K | ﹤0.01% | 242 |
|
|
2016
Q2 | – | Sell |
-10,300
| Closed | -$3.71M | – | 468 |
|
|
2016
Q1 | $3.71M | Hold |
10,300
| – | – | 0.62% | 60 |
|
|
2015
Q4 | $5.59M | Buy |
10,300
+4,500
| +78% | +$2.44M | 0.81% | 44 |
|
|
2015
Q3 | $2.7M | Sell |
5,800
-9,200
| -61% | -$4.28M | 0.36% | 82 |
|
|
2015
Q2 | $7.65M | Buy |
+15,000
| New | +$7.65M | 0.89% | 27 |
|